Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

711
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
711
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

393
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
393
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

581
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
581
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

611
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
611
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

359
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
359

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral glucocorticoid premedication for preventing infusion-related reactions to rituximab in rheumatoid arthritis.

Scandinavian journal of rheumatology·2026
Same author

Similar gout flare incidence rates when using once- or twice-daily 0.5 mg colchicine prophylaxis after the start of xanthine oxidase inhibitors.

Scandinavian journal of rheumatology·2025
Same author

Disease Activity Score in 28 joints using C-reactive protein based remission state and still residual swollen joints: theoretically possible, but does it occur in the real world?

Scandinavian journal of rheumatology·2025
Same author

Improving the noise estimation of latent neural stochastic differential equations.

Chaos (Woodbury, N.Y.)·2025
Same author

Cost-utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations.

Scandinavian journal of rheumatology·2024
Same author

Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.

Clinical rheumatology·2024

Related Experiment Video

Updated: Feb 17, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.2K

[Polymyalgia rheumatica: new developments and challenges].

D E Marsman1, A A den Broeder, N Boers

  • 1Sint Maartenskliniek, afd. Reumatologie, Ubbergen.

Nederlands Tijdschrift Voor Geneeskunde
|December 2, 2017
PubMed
Summary

Polymyalgia rheumatica (PMR) is an inflammatory disorder often diagnosed using elevated inflammatory markers, though normal levels don't rule it out. Glucocorticoids are the primary treatment, with ongoing research into steroid-sparing alternatives.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.3K
Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.8K

Related Experiment Videos

Last Updated: Feb 17, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.2K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.3K
Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
06:14

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

2.8K

Area of Science:

  • Rheumatology
  • Internal Medicine

Background:

  • Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disorder characterized by elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels.
  • PMR diagnosis presents challenges due to its arbitrary nature and potential for normal inflammatory marker values.
  • Current diagnostic approaches for PMR are primarily clinical, with imaging modalities reserved for complex cases.

Purpose of the Study:

  • To review the diagnostic and therapeutic landscape of polymyalgia rheumatica.
  • To discuss the role of imaging in PMR diagnosis.
  • To explore current and emerging treatment strategies for PMR.

Main Methods:

  • Literature review of diagnostic criteria and treatment outcomes for polymyalgia rheumatica.
  • Analysis of the utility of imaging techniques (echography, MRI, FDG-PET/CT) in PMR diagnosis.
  • Evaluation of evidence for glucocorticoid and steroid-sparing therapies in PMR management.

Main Results:

  • Inflammation markers (ESR, CRP) are often elevated in PMR but not always, complicating diagnosis.
  • Glucocorticoids are the mainstay of PMR treatment, with variable response times and typical treatment durations of 1-3 years.
  • Methotrexate shows the most evidence among steroid-sparing agents, with limited data on azathioprine, leflunomide, and promising but preliminary results for tocilizumab.

Conclusions:

  • PMR diagnosis requires careful clinical assessment, potentially aided by imaging in ambiguous cases.
  • Glucocorticoid therapy is effective but associated with long treatment courses and potential side effects.
  • Further research is needed to establish the efficacy and safety of steroid-sparing agents, including tocilizumab, for long-term PMR management.